Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes

BACKGROUND: Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TILs) is a promising experimental immunotherapy that has shown high objective responses in patients with melanoma. Current protocols use a lymphodepletive chemotherapy before infusion of ex vivo expanded TILs, followed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Orcurto, Angela, Hottinger, Andreas, Wolf, Benita, Navarro Rodrigo, Blanca, Ochoa de Olza, Maria, Auger, Aymeric, Kuntzer, Thierry, Comte, Denis, Zimmer, Virginie, Gannon, Philippe, Kandalaft, Lana, Michielin, Olivier, Zimmermann, Stefan, Harari, Alexandre, Trueb, Lionel, Coukos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451492/
https://www.ncbi.nlm.nih.gov/pubmed/32847987
http://dx.doi.org/10.1136/jitc-2020-001155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451492/
https://www.ncbi.nlm.nih.gov/pubmed/32847987
http://dx.doi.org/10.1136/jitc-2020-001155

Ejemplares similares